Splenic T cells isolated from BALB/c mice that had been mucosally tolerized by oral administration of 25 mg of OVA revealed selective increases in IFN-γ production with impaired levels of IL-2, IL-4, IL-5, and IL-10. These mice possessed reduced splenic OVA-specific T cell proliferative and delayed-type hypersensitivity responses when compared with nontolerized controls. Further, OVA-specific IgG Ab responses in serum and the numbers of IgG Ab-forming cells in spleen were significantly diminished following systemic challenge with OVA in CFA. When IFN-γ-deficient (IFN-γ−/−) mice of the same genetic background were given an oral dose of 25 mg of OVA before systemic immunization, no reduction in OVA-specific IgG Ab responses in serum and spleen was seen. Furthermore, the serum IgG Ab responses were restricted to IgG1 and IgG2b subclasses. Interestingly, although IFN-γ−/− mice displayed a partial diminishment of T cell proliferative and delayed-type hypersensitivity responses to OVA, significant responses were still present when compared with the low responses noted in IFN-γ+/+ mice. In addition, OVA-specific T cells from IFN-γ−/− mice produced Th2-type cytokines (e.g., IL-4), which provided help for systemic OVA-specific serum IgG1 and IgG2b Ab responses. These findings clearly indicate a central role for IFN-γ in the induction and maintenance of mucosally induced tolerance.
Lack of Orally Induced Systemic Unresponsiveness in IFN-γ Knockout Mice
M. Kweon,K. Fujihashi,J. Vancott,K. Higuchi,Masafumi Yamamoto,J. Mcghee,H. Kiyono
Published 1998 in Journal of Immunology
ABSTRACT
PUBLICATION RECORD
- Publication year
1998
- Venue
Journal of Immunology
- Publication date
1998-02-15
- Fields of study
Not labeled
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-39 of 39 references · Page 1 of 1
CITED BY
Showing 1-35 of 35 citing papers · Page 1 of 1